SLU-PP-332 x 100 [250mcg] Tablets

REV-ERB Agonist | Circadian Rhythm, Metabolism & Fat Oxidation Research | USA Manufactured & Third-Party Tested

SLU-PP-332 is a synthetic small-molecule compound classified as a REV-ERB nuclear receptor agonist, primarily studied for its potential role in regulating circadian rhythms, mitochondrial function, lipid metabolism, and energy expenditure. By targeting the REV-ERBα and REV-ERBβ receptors, SLU-PP-332 has shown promise in preclinical research involving metabolic disorders, obesity, and sleep-wake cycle modulation.

Each 5mg vial is supplied as a lyophilized powder to preserve compound stability and ensure accurate dosing in laboratory settings. SLU-PP-332 is manufactured in a U.S.-based facility and third-party tested for >99% purity, providing researchers with a reliable compound for advanced metabolic and chronobiology research.

Key Features

• (100) 250mcg SLU-PP-332 tablets per bottle

• Synthetic REV-ERBα/β receptor agonist

• Manufactured in the USA

• Third-party tested for >99% purity and identity

• Supports studies on circadian biology, fat oxidation, and metabolic regulation

• For research use only – not for human consumption

Disclaimer: This compound is intended strictly for laboratory research purposes only. It is not a drug, food, or cosmetic, and is not intended for human use or consumption under any circumstances.